Trial Profile
Fluoxetine in Pediatric Body Dysmorphic Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2018
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Body dysmorphic disorder
- Focus Therapeutic Use
- 01 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Dec 2010 Planned end date changed from 1 Dec 2008 to 1 Mar 2012 as reported by ClinicalTrials.gov.